Silence Therapeutics plc
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
20.01 |
21.68 |
23.23 |
30.58 |
561.29 |
239.94 |
| Przychód Δ r/r |
0.00% |
8.39% |
7.12% |
31.66% |
1735.41% |
-57.25% |
| Przychód (min) |
15.48 |
2.82 |
10.13 |
5.41 |
99.30 |
42.45 |
| Przychód (max) |
26.41 |
57.64 |
48.39 |
78.97 |
1,449.45 |
619.60 |
| EBITDA (średnia) |
-20.01 |
-21.68 |
-23.23 |
-30.58 |
-561.29 |
-239.94 |
| EBIT (średnia) |
-20.01 |
-21.68 |
-23.23 |
-30.58 |
-561.29 |
-239.94 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-27.23 |
-22.19 |
-19.40 |
-17.25 |
146.35 |
-15.99 |
| Zysk netto % |
-136.13% |
-102.31% |
-83.53% |
-56.42% |
26.07% |
-6.66% |
| EPS (średnia) |
-0.58 |
-0.47 |
-0.41 |
-0.37 |
3.10 |
-0.34 |
| Liczba analityków (Przychody) |
5 |
5 |
7 |
3 |
4 |
3 |
| Liczba analityków (EPS) |
4 |
4 |
4 |
2 |
3 |
2 |
| symbol |
SLN |
SLN |
SLN |
SLN |
SLN |
SLN |